Ral Guanine Nucleotide Dissociation Stimulator (RALGDS) (N-Term) Peptide
RALGDS
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all RALGDS products
- RALGDS (Ral Guanine Nucleotide Dissociation Stimulator (RALGDS))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-RALGDS antibody (Catalog #: ARP56275_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- RALGDS (Ral Guanine Nucleotide Dissociation Stimulator (RALGDS))
- Synonyms
- RGDS Peptide, RGF Peptide, RalGEF Peptide, Gnds Peptide, Rgds Peptide, mKIAA1308 Peptide, RALGDS Peptide, ral guanine nucleotide dissociation stimulator Peptide, RALGDS Peptide, Ralgds Peptide, ralgds Peptide
- Background
-
The specific function of this protein remains unknown.
Alias Symbols: FLJ20922, RGF, RalGEF, RGDS
Protein Interaction Partner: HRAS,MAPK3,RAP1A,ARRB1,ARRB2,CNKSR1,HRAS,KRAS,MAPK3,MLLT4,MRAS,NF2,PDPK1,RAP1A,RAP1GAP,RAP2A,RAP2B,RIT1,RIT2,RRAS,RRAS2,ARRB1,ARRB2,CNKSR1,HRAS,KRAS,LRPAP1,MRAS,PDK1,RAP1A,RAP2A,RAP2B,RAPGEF2,RIN1,RIT1,RRAS,RRAS2
Protein Size: 859 - Molecular Weight
- 95 kDa
- Gene ID
- 5900
- NCBI Accession
- NM_001042368, NP_001035827
- UniProt
- Q6KH11
-
You are here:
